NYSE:CRLLife Sciences
Assessing Charles River Laboratories (CRL) Valuation After Recent Share Recovery And Conflicting Fair Value Signals
Recent share performance and business profile
Charles River Laboratories International (CRL) has drawn investor attention after recent share price moves, with the stock up about 5% over the past month and roughly 11% over the past 3 months.
The company provides drug discovery, non clinical development, and safety testing services. It generates about US$4.0b in revenue and operates across the United States, Europe, Canada, and the Asia Pacific region.
See our latest analysis for Charles River...